|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ChiCTR |
|
Last refreshed on:
|
18 April 2017 |
|
Main ID: |
ChiCTR-TRC-09000332 |
|
Date of registration:
|
2009-01-08 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Adaptability clinical trail of angina pectorias treated with xinxuekang capsule
|
|
Scientific title:
|
Adaptability clinical trail of angina pectorias treated with xinxuekang capsule |
|
Date of first enrolment:
|
2009-02-01 |
|
Target sample size:
|
experiment:368;comparison:368; |
|
Recruitment status: |
Completed |
|
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=9199 |
|
Study type:
|
Interventional study |
|
Study design:
|
Randomized parallel controlled trial
|
|
Phase:
|
Post-market
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
Wang Zhong
|
|
Address:
|
16 Nanxiaojie street, Dongzhimen Nei, Dongcheng District, Beijing
100700
|
|
Telephone:
|
+86 0 13601315446 |
|
Email:
|
zhonw@sina.com |
|
Affiliation:
|
|
|
|
Name:
|
Su Liya
|
|
Address:
|
16 Nanxiaojie street, Dongzhimen Nei, Dongcheng District, Beijing
100700
|
|
Telephone:
|
+86 0 15101016441 |
|
Email:
|
suliya5641@163.com |
|
Affiliation:
|
Institute of Basical clinical Medcine, China Academy of Chinese Medical sciences |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Patients with angina of effort and stable angina cordis disease of effort I, II, III stage; be the TCM signs of "Xue Yu" (blood stasis syndrome); Age 40~70 years old; the test-receiver know what happened, and sign informed consent.
Exclusion criteria: Who expirenced heart interventional therapy and after CABG operation; Pregnancy or suckling women; Allergic physical endowment and allergy to various medicine; Who attend other clinical trial in last a month.
Age minimum:
40
Age maximum:
70
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Coronary heart disease (Angina)
|
|
32012410
|
|
Intervention(s)
|
|
experiment:Xin Xue Kang capsule;comparison:Compound Danshen pill;
|
|
Primary Outcome(s)
|
|
remission of angina attack;cardiograph;
|
|
Secondary Outcome(s)
|
|
blood lipides concentration;Change of TCM sign;
|
|
Source(s) of Monetary Support
|
|
Chengdu Di Ao corporation Ltd.
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|